Search

everythinglearnresearchcommunity

for

Search:↓

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

Granzyme B accelerates skin aging and impairs healing by breaking down important skin components.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Women with early onset androgenetic alopecia have worse lipid profiles.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.